Research Groups and R&D Platforms: In Vivo Diagnostics

R&D Platform:
Turku BioImaging

Turku BioImaging, TBI (www.bioimaging.fi), is an umbrella organization for “all things imaging” in Turku, jointly operated by Åbo Akademi University and the University of Turku. TBI was initiated in 2007 as a broad-based, interdisciplinary imaging consortium that aims at bringing together all biological and medical imaging expertise in Turku and elsewhere in Finland. In 2017, Turku BioImaging is celebrating its journey of 10 years, from a small 2-person unit to a large, fully functioning organization.

Read more

Atomic-force microscopy, Basic research, Clinical development, Diagnostics, Electron microscopy, FTIR or RAMAN microscopy, High throughput imaging, Imaging, Imaging software, In Vivo Diagnostics, PET, Preclinical development, R&D Platforms, Super-resolution imaging, Ultrasound imaging

R&D Platform:
Cancer Centre of the Turku University Hospital

The Tyks Cancer Centre guarantees high-quality cancer treatment and research in the hospital districts of Southwest Finland, Satakunta and Vaasa.

The Tyks Cancer Centre works to unify treatment practices and treatment quality, and to see to it that patients get access to treatment according to unified criteria in a timely manner in the western coastal area of Finland. This puts the patients with cancer at the right place at the right time, regardless of where they live. 

The Tyks Cancer Centre is a part of the Cancer Center Finland (FICAN) – a national enterprise under construction to coordinate cancer treatment, research and education in the whole of Finland.

The Tyks Cancer Centre

Breast cancer, Cancer, Clinical development, Colorectal cancer, Diagnostics, In Vitro Diagnostics, In Vivo Diagnostics, Lung cancer, Melanoma, Ovarian cancer, Prostate cancer, R&D Platforms, Squamous cell carcinoma

Research Group:
Early detection of Alzheimer´s disease: a translational study

Juha Rinne
juha.rinne[at]tyks.fi

Turku PET Centre, University of Turku and
Division of Clinical Neurosciences, Turku University Hospital

turkupetcentre.fi

Ageing-related diseases, Biomarker, Clinical development, Clinical Medicine, Diagnostics, Imaging, In Vivo Diagnostics, Molecular diagnostics, Neurological disorders, PET, Receptor

Research Group:
Imaging Alzheimer’s disease beta-amyloid pathology in transgenic mouse models using positron emission tomography

Francisco López-Picón
fralop[at]utu.fi

Turku PET Centre, Preclinical Imaging,
University of Turku

Turku PET Centre

Ageing-related diseases, Biomarker, Biomedicine, Biopharmaceuticals, Clinical Medicine, Disease models, Drug delivery, Drug target, Epigenomics, Imaging, Imaging software, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Molecular Biology, Molecular diagnostics, Neurological disorders, Pathology, PET, Pharmacology, Physiology, Preclinical development, Proteomics, Target discovery

Research Group:
PET imaging of neuropathological changes in animal models of Alzheimer’s disease

Merja Haaparanta-Solin
mehaaso[at]utu.fi

Turku PET Centre, Preclinical Imaging,
University of Turku

https://www.utu.fi/en/units/med/research/research_projects/Pages/merja-haaparanta-solin.aspx

Turku PET Centre

Ageing-related diseases, Antibodies, Autoimmune diseases, Basic research, Biochemistry, Biomarker, Biomedicine, Cardiovascular diseases, Diabetes, Disease models, Drug target, Imaging, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Metabolic diseases, Nanoparticles, Neurological disorders, Organic compounds, PET, Pharmacology, Preclinical development, Receptor, Target discovery

Research Group:
Molecular epidemiology, carriage and antimicrobial susceptibility of bacterial pathogens

Jaana Vuopio
jaana.vuopio[at]utu.fi

Department of Medical Microbiology and Immunology,
University of Turku

http://www.utu.fi/en/units/med/units/immunology/research/Pages/vuopio.aspx

Antibacterial, Antibodies, Bacteriology, Basic research, Bioinformatics, Biomarker, Biomedicine, Clinical Medicine, Data mining, Diagnostics, Epidemiology, Genetics, Genomics, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Infection, Inflammation, Molecular diagnostics, Next-generation sequencing, Nucleic acids, Personalized medicine, Point of care, Receptor